Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

ARNA 2.70 0.00 (0.00%)
price chart
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Fights for Share of Weight-loss Pill ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA, ARNA message board) is expected to launch its patented Belviq treatment early next year, but there are some doubts that by that time Vivus, Inc. (NASDAQ:VVUS) will have made its Qsymia something of a ...
With Arena, Patience Is A Virtue
Disclosure: I am long ARNA. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha).
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
In addition, Arena comes with some enticing benefits for a pharmaceutical suitor - 10 year Swiss Tax Haven and R&D Write-offs.
Obesity Drugs Gain Attention on FDA Backing for Therapies
Third Rock Ventures is an early backer of Zafgen Inc., a biotechnology company in mid-stage trials of a therapy to treat obesity. The Food and Drug Administration cleared Belviq, from Arena Pharmaceuticals Inc. and Eisai Co., in June and Vivus Inc.'s ...
All Eyes On Vivus As Weight Loss Drug Hits Market  YCharts
Promentis receives grant to develop schizophrenia drugs
Milwaukee-based Promentis Pharmaceuticals Inc. has received a three-year, $1.8 million award from the National Institutes of Health to develop more effective drugs to treat schizophrenia.
The Rev. Sun Myung Moon to be laid to rest in South Korea
Prayers, singing, floral tributes and eulogies are expected as the remains of Moon arrive at the arena. After a two-hour ceremony, he will be laid to rest on Mount Cheonseong in the northern South Korean province of Gyeonggi -- known as the "holy land ...
Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines
Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech a member of the Roche Group, and Sanofi launched TransCelerate BioPharma Inc. ("TransCelerate"), the largest ...
Dr. Jean-Paul Castaigne, CEO of Angiochem
Yet the most exciting developments for Angiochem this year have been in the rare-diseases arena. The company raised its profile and brought publicity to its preclinical efforts in transporting enzyme drugs for orphan disorders into the brain in ...
Testosterone boosters sell to millions
Watson Pharmaceuticals Inc. now markets its Androderm patch, which slowly releases testosterone into the bloodstream. Abbott has its gel that can be applied to the shoulders and arms.
UW foundation sees severe drop in drug licensing income
Also, DeLuca has a drug development company called Deltanoid Pharmaceuticals that "is a very valuable company," Gulbrandsen said. WARF has other pharmaceuticals that have shown promise, although not on the order of Zemplar, and start-ups like ...